<DOC>
	<DOCNO>NCT00806195</DOCNO>
	<brief_summary>The primary objective phase 3b study evaluate safety tolerability Novartis MenACWY conjugate vaccine administer routine infant vaccination healthy infant</brief_summary>
	<brief_title>Study Evaluate Safety Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>healthy 2monthold infant ( age 55 89 day ) ; baby must bear fullterm pregnancy estimate gestation age ≥37 week birth weight ≥2.5 kg parent/legal representative give write informed consent nature study explain ; available visit schedule study ; good health determine medical history physical assessment . previously receive meningococcal vaccine D , T , P , IPV OPV , H influenzae type b ( Hib ) Pneumococcus ; prior dos BCG ( one ) and/or HBV ( two ) permit previous confirm suspected disease cause N meningitidis , C diphtheriae , C tetani , Poliovirus , Hepatitis B , Hib , Pneumococcus B pertussis ( history laboratory confirm , clinical condition paroxysmal cough period longer equal 2 week associate apnea whoop ) ; household contact and/or intimate exposure individual laboratory confirm N meningitidis ( serogroups A , C , W135 , Y ) , B pertussis , Hib , C diphtheriae , Polio , pneumococcal infection time since birth ; history anaphylactic shock , asthma , urticaria allergic reaction previous vaccination know hypersensitivity vaccine component ; experience significant acute chronic infection within previous 7 day experience fever ( axillary temperature ≥ 38.0°C [ 100.4°F ] ) within previous 3 day ; present suspect serious acute ( e.g . leukemia , lymphoma ) , chronic disease ( e.g. , sign cardiac disease , renal failure , severe malnutrition , insulin dependent diabetes ) , progressive neurological disease , genetic anomaly/known cytogenic disorder ( e.g. , Down 's syndrome ) ; know suspect autoimmune disease persistent impairment/alteration immune function result ( example ) : 1. receipt immunosuppressive therapy time since birth 2. receipt immunostimulants time since birth 3. receipt systemic corticosteroid since birth ; suspect know HIV infection HIV related disease ; ever receive blood , blood product and/or plasma derivative parenteral immunoglobulin preparation ; know bleeding diathesis , condition may associate prolonged bleeding time ; history seizure ; parents/legal representative plan leave area study site end study period ; condition , opinion investigator , might interfere evaluation study objective ; receive investigational agent vaccine since birth expect receive investigational agent vaccine prior completion study . relatives site research staff work study .</criteria>
	<gender>All</gender>
	<minimum_age>55 Days</minimum_age>
	<maximum_age>89 Days</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>vaccine</keyword>
	<keyword>infant</keyword>
	<keyword>healthy</keyword>
	<keyword>meningitis</keyword>
	<keyword>meningococcal</keyword>
</DOC>